Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Condensed Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenue (including from related parties, see note 12)	$ 6,473	$ 19,516
Operating expenses:
Research and development	31,526	27,092
General and administrative	9,640	8,607
Total operating expenses	41,166	35,699
Operating loss	(34,693)	(16,183)
Other income, net:
Interest income	3,291	4,867
Other income	418
Total other income, net	3,709	4,867
Loss before income taxes	(30,984)	(11,316)
Income tax provision	37	14
Net loss	(31,021)	(11,330)
Other comprehensive gain (loss):
Net unrealized gain (loss) on available-for-sale securities	208	(458)
Total other comprehensive gain (loss)	208	(458)
Comprehensive loss	$ (30,813)	$ (11,788)
Net loss per share, basic (in dollars per share)	$ (0.53)	$ (0.2)
Net loss per share, diluted (in dollars per share)	$ (0.53)	$ (0.2)
Weighted-average common shares outstanding, basic (in shares)	58,349,769	57,117,046
Weighted-average common shares outstanding, diluted (in shares)	58,349,769	57,117,046